Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma.
Porth I, Hirsch D, Ceribas Y, Weidner P, Weichert W, Götze TO, Perner S, Luley K, Heyer CM, de la Torre C, Hofheinz RD, Lorenzen S, Gaiser T. Porth I, et al. Among authors: perner s. Eur J Cancer. 2023 Apr;183:119-130. doi: 10.1016/j.ejca.2023.01.022. Epub 2023 Feb 3. Eur J Cancer. 2023. PMID: 36848831 Free article.
Fibroblast growth factor receptor 1 as a putative therapy target in colorectal cancer.
Göke F, Göke A, von Mässenhausen A, Franzen A, Sharma R, Kirsten R, Böhm D, Kristiansen G, Stenzinger A, Wynes M, Hirsch FR, Weichert W, Heasley L, Buettner R, Perner S. Göke F, et al. Among authors: perner s. Digestion. 2013;88(3):172-81. doi: 10.1159/000355018. Epub 2013 Oct 17. Digestion. 2013. PMID: 24135816 Free PMC article.
Cyclin K dependent regulation of Aurora B affects apoptosis and proliferation by induction of mitotic catastrophe in prostate cancer.
Schecher S, Walter B, Falkenstein M, Macher-Goeppinger S, Stenzel P, Krümpelmann K, Hadaschik B, Perner S, Kristiansen G, Duensing S, Roth W, Tagscherer KE. Schecher S, et al. Among authors: perner s. Int J Cancer. 2017 Oct 15;141(8):1643-1653. doi: 10.1002/ijc.30864. Epub 2017 Jul 12. Int J Cancer. 2017. PMID: 28670704 Free article.
NR2F6 as a Prognostic Biomarker in HNSCC.
Klapper L, Ribbat-Idel J, Kuppler P, Paulsen FO, Bruchhage KL, Rades D, Offermann A, Kirfel J, Wollenberg B, Idel C, Perner S. Klapper L, et al. Among authors: perner s. Int J Mol Sci. 2020 Aug 1;21(15):5527. doi: 10.3390/ijms21155527. Int J Mol Sci. 2020. PMID: 32752295 Free PMC article.
Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy.
Klusa D, Lohaus F, Franken A, Baumbach M, Cojoc M, Dowling P, Linge A, Offermann A, Löck S, Hušman D, Rivandi M, Polzer B, Freytag V, Lange T, Neubauer H, Kücken M, Perner S, Hölscher T, Dubrovska A, Krause M, Kurth I, Baumann M, Peitzsch C. Klusa D, et al. Among authors: perner s. Int J Cancer. 2023 Jun 15;152(12):2639-2654. doi: 10.1002/ijc.34457. Epub 2023 Mar 13. Int J Cancer. 2023. PMID: 36733230
TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC.
von Bernuth A, Ribbat-Idel J, Klapper L, Jagomast T, Rades D, Leichtle A, Pries R, Bruchhage KL, Perner S, Offermann A, Sailer V, Idel C. von Bernuth A, et al. Among authors: perner s. Int J Mol Sci. 2023 Mar 7;24(6):5140. doi: 10.3390/ijms24065140. Int J Mol Sci. 2023. PMID: 36982215 Free PMC article.
320 results